|
Market Closed -
OTC Markets
03:18:04 04/12/25 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 5 years | 0 |  | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 02/08/2012 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 20/01/2010 |
Steven Byle
BRD | Director/Board Member | 58 | 09/11/2009 |
Roger Fidler
BRD | Director/Board Member | 75 | 30/12/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +2.70% | +0.35% | +40.67% | +110.31% | 1,032B | |
| +1.44% | -3.41% | +37.36% | +63.95% | 614B | |
| +1.75% | +3.07% | +17.89% | +83.05% | 471B | |
| +0.60% | -4.35% | +60.80% | +37.46% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.60% | -2.49% | +40.45% | +54.44% | 218B | |
| +1.82% | -2.93% | +29.29% | +96.48% | 179B | |
| Average | +1.64% | -2.41% | +28.89% | +59.87% | 371.48B | |
| Weighted average by Cap. | +1.98% | -2.81% | +32.16% | +70.59% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
